PRESS RELEASE published on 06/27/2023 at 12:58, 3 years ago Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
PRESS RELEASE published on 06/27/2023 at 12:55, 3 years ago Rights and Issues Investment Trust PLC: AMENDMENT - Net Asset Value(s)
PRESS RELEASE published on 06/26/2023 at 12:59, 3 years ago Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
PRESS RELEASE published on 06/23/2023 at 13:29, 3 years ago Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
PRESS RELEASE published on 06/22/2023 at 12:06, 3 years 1 month ago Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
PRESS RELEASE published on 06/21/2023 at 12:53, 3 years 1 month ago Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
PRESS RELEASE published on 06/20/2023 at 12:59, 3 years 1 month ago Rights and Issues Investment Trust PLC: Net Asset Value(s)
PRESS RELEASE published on 06/19/2023 at 12:22, 3 years 1 month ago Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
PRESS RELEASE published on 06/16/2023 at 13:39, 3 years 1 month ago Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
PRESS RELEASE published on 06/15/2023 at 12:47, 3 years 1 month ago Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Published on 07/22/2026 at 15:00, 2 hours 56 minutes ago Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 2 hours 56 minutes ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:35, 3 hours 21 minutes ago Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 3 hours 26 minutes ago As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Published on 07/22/2026 at 17:45, 11 minutes ago VAZIVA SA: S1 2026 : VAZIVA RENFORCE LES FONDATIONS DE SA FUTURE CROISSANCE
Published on 07/22/2026 at 17:40, 16 minutes ago VALBIOTIS SA: Les résultats de l’étude clinique REVERSE-IT publiés dans Nature Communications, une reconnaissance scientifique internationale majeure pour l’ingrédient Totum•63
Published on 07/22/2026 at 17:40, 16 minutes ago VALBIOTIS SA: Results of the REVERSE-IT clinical study published in Nature Communications, a major international scientific recognition for the ingredient Totum•63
Published on 07/22/2026 at 16:49, 1 hour 7 minutes ago Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
Published on 07/22/2026 at 16:30, 1 hour 26 minutes ago Befar Group Achieves Mass Production of 6N-Grade High-Purity Hydrogen Fluoride
Published on 07/22/2026 at 17:45, 11 minutes ago Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Published on 07/22/2026 at 17:45, 11 minutes ago Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).
Published on 07/22/2026 at 17:40, 16 minutes ago Déclaration des transactions sur actions propres réalisées du 15 au 21 juillet 2026
Published on 07/22/2026 at 15:26, 2 hours 30 minutes ago Chiffres d'Affaires du 1er Trimestre de l'Exercice 2026/2027
